Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience

Total article views   HTML views PDF downloads Totals
1,597 Dovepress* 1,485+ 39 1,524
PubMed Central* 112 49 161
Totals 1,597 88 1,685
*Since 20 December 2023

View citations on PubMed Central and Google Scholar